In the current study, 126 newly diagnosed, non-metastatic NPC patients with consecutive follow-ups were reviewed retrospectively with the primary goal of determining the long-term prognostic importance of HO-1 expression in NPC. The gene discussed is HMOX1; the disease is nasopharyngeal carcinoma.